We
consult, write, and speak on critical issues that determine the success of life
science companies. Working together with our partners in the Biopharmaceutical
Consortium and Innovalyst,
we help your company increase the effectiveness of its drug and diagnostic discovery
and development, commercialization of new research products, assessment of new
business opportunities, and partnering.
Our typical
consulting engagements have included:
- Strategic
new product and R&D planning
- Opportunity assessment and assistance
in partnering
- Technology assessment
- Assessment of pipeline drugs
and assistance in go/no go decisions
- Proprietary strategic reports on
areas for potential business expansion
- Due diligence on potential partners
and investment or acquisition candidates
For further
details on consulting services we have provided, please
click here.
Our clients principally include
pharmaceutical, biotechnology, diagnostics, and research products companies of
all sizes, from startups to major corporations. We serve clients on a worldwide
basis, mainly in North America, Europe, and Japan.
Our
books and reports have been published by such leading organizations as Decision
Resources, Cambridge Healthtech Institute, and Informa Healthcare.
Our
articles have appeared in such leading publications as Genetic Engineering
News, Pharma DD, and PharmaWeek. See our home
page for examples.
We also publish articles on our
Biopharmconsortium
Blog, which we started in July 2009.
Our principal,
Allan B. Haberman, has been quoted in such publications as Pharmaceutical Executive,
Business Week, Nature Biotechnology, New Scientist, Mass
High Tech, and Sacramento Business Journal.
We
also speak and teach in business and academic settings.
Haberman Associates is a member of the New
England Chapter of the Institute of Management Consultants (IMCNE) and of
the Society of Professional
Consultants (SPC). We subscribe to the IMC and SPC codes of ethics, and strive
to uphold high ethical standards as well as excellence in client service and in
expert advice and counsel.
